Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel)
DRUG
2 trials
Sponsors
Samsung Medical Center
, Ochsner Health System
Conditions
Acute Coronary Syndrome
Coronary Arterial Disease (CAD)
Peripheral Vascular Disease
Phase 4
Colonoscopy and Antiplatelet Therapy Trial
Not yet recruiting
NCT06613191
Ochsner Health System
Coronary Arterial Disease (CAD), Peripheral Vascular Disease
Start: 2024-10-01
End: 2026-06-30
Target: 100
Updated: 2024-09-25
Unknown Phase
Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE)
NCT01701453
Samsung Medical Center
Acute Coronary Syndrome
Start: 2012-08-31
End: 2019-11-30
Updated: 2018-02-08
Related Papers
Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Circulation Cardiovascular Interventions
2020-05-01
36 citations
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
2018-03-12
253 citations